Clinical trial
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared…
NCT00011921 · EBMT Solid Tumors Working Party, Other · Unknown status
Key facts
| NCT number | NCT00011921 |
|---|---|
| Title | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer |
| Official title | Phase III Randomized Trial of Sequential High-Dose Chemotherapy Versus Standard Chemotherapy for the Treatment of Small Cell Lung Cancer |
| Lead sponsor | EBMT Solid Tumors Working Party, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, carboplatin, epirubicin hydrochloride, etoposide, etoposide phosphate, ifosfamide, paclitaxel, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation and 1 more |
| Enrollment | 430 |
| Start date | Sep 1, 1997 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: